Development Status

iPSC Regenerative Medicine

【Ophthalmology Area】

Development Code Indication Market Pre-clinical test Apply-approve On the Market Progress Status
HLCR011 Wet AMD Japan
Transplantation conducted
under Clinical research(*1)
Undergoing preparation for clinical trial
Development Code Indication Market Pre-clinical test Phase I Trial Phase II Trial Phase III Trial Apply-approve On the Market Progress Status
HLCR012 Dry AMD US
CRADA with NEI
HLCR012 Dry AMD EU
Global trial under consideration based on US phase III trial
  1. “Clinical research of transplantation of induced pluripotent stem cells – derived retinal pigment epithelium (RPE) cells for exudative age-related macular degeneration (AMD)” conducted by RIKEN etc.

【Liver Disease】

Development Code Indication Market Pre-clinical test Apply-approve On the Market Progress Status
HLCL041 Metabolic Liver Disease Japan
ONL established

Somatic Stem Cell Regenerative Medicine

Development Code Indication Market Pre-clinical test Apply-approve On the Market Progress Status
HLCM051 Ischemic Stroke Japan
Clinical trial ongoing
HLCM051 ARDS Japan
Undergoing preparation for administration